Author: Peter Norman, PhD, MBA

Tables
Table 2.1. Families of Ion Channels
Table 2.2. Voltage-Gated Calcium Channels
Table 2.3. Old and New Nomenclatures of Glutamate-Gated Ion Channels
Table 4.1. L-Type Calcium Channel Blockers and 2007 Sales
Table 4.2. KATP Channel Modulators and 2007 Sales
Table 4.3. GABAA Channel Modulators and 2007 Sales
Table 4.4. Class I Antiarrhythmic Agents (Sodium Channel Blockers)
Table 4.5. Class III Antiarrhythmic Agents (Potassium Channel Blockers)
Table 4.6. Anticonvulsant Agents and 2007 Sales
Table 4.7. 5-HT3 Antagonists and 2007 Sales
Table 5.1. Ion Channel Modulators Awaiting Regulatory Approval
Table 5.2. Ion Channel Modulators in Phase III Studies
Table 5.3. Ion Channel Modulators in Phase II Studies for CNS Disorders
Table 5.4. Ion Channel Modulators for Non-CNS Conditions in Phase II Studies
Table 5.5. Ion Channel Modulators in Phase I Studies

Figures
Figure 5.1. Ion Channels Modulators in Development by Major Pharmaceutical Companies
Figure 5.2. Ion Channel Modulators in Development by Target Type
Figure 5.3. Ion Channel Modulators in Development by Indication
Figure 6.1. Ion Channel Modulator Patents Filed by Seven Major Companies Published Between January 2005 and March 2009